NCT07518407
Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy
Recruiting
NAAges 18–65InterventionalUniversity of South CarolinaInvestigator-initiated
~50 participants
Updated 2026-06-12 on ClinicalTrials.gov
What's tested:SWITCH Diets - Mobile Nutrition Behavioral Intervention
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Intervention acceptability, usefulness and ease of use
Measured over End of 6-week intervention
Conditions
Where it's being run
1 sites across 1 statesSouth Carolina1
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
• Age between 18 and 65 years.
BMI between 30 - 49.9 kg/m2 and/or diagnosed with type 2 diabetes.
Currently prescribed and using GLP-1 receptor therapy for at least 4 weeks.
Own a smartphone (Android or iOS) with an active data plan to support app-based intervention delivery.
Residing anywhere in the United States.
Must be willing and able to reduce caloric intake.
Be free of major health or psychiatric diseases, drug, or alcohol dependency.
Willing to sign informed consent.
Exclusion
• Presence of type 1 diabetes mellitus
Severe complications, including but not limited to proliferative retinopathy, severe peripheral neuropathy, nephropathy requiring dialysis, active foot ulcers, or recent hospitalization for diabetic ketoacidosis or hyperosmolar hyperglycemic state within the past 6 months.
Current or recent (within 6 months) participation in another structured weight loss program or clinical trial that may interfere with study outcomes.
Pregnancy, breastfeeding, or plans to become pregnant during the study period.
Current use of another investigational weight loss device or medication.
Diagnosed eating disorders (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder) or other psychiatric conditions that may affect adherence to behavioral interventions, as determined by study staff.
Severe cardiovascular, hepatic, renal, or pulmonary disease that would limit participation in moderate physical activity or dietary modification.
Active cancer treatment (chemotherapy, radiation, or surgery) within the past 12 months.
Substance use disorder or alcohol dependency within the past 12 months.
Cognitive impairment or any medical or mental condition that would interfere with the ability to understand or comply with study procedures.
Lack of reliable internet or smartphone access, or unwillingness to use a mobile app for tracking and communication.
What this trial measures
- Intervention acceptability, usefulness and ease of useEnd of 6-week intervention
Acceptability, satisfaction, and perceived burden of the intervention, assessed using the Treatment Acceptability and Preferences (TAP) measure(0-10 scale; 0 = not at all, 10 = extremely), with 0-3 indicating low and 7-10 high levels (higher burden = less favorable). Perceived usefulness, ease of use, and intention to use digital tools, assessed using the Technology Acceptance Model (TAM) survey (1-5 Likert scale; 1 = strongly disagree, 5 = strongly agree), with 1.0-2.4 indicating low and 3.5-5.0 high levels.